Physician profile
Mitchell A Kerner
NPI 1356975940
$13,025.88
in general payments reported to CMS, 2019-2025
46 companies · $3,725 in 2025
The $3,725 reported for 2025 was more than what 97% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,532 · 2022: $2,328 · 2023: $2,892 · 2024: $2,549 · 2025: $3,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,067 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,066.72 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,280.91 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,470.37 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,193.51 | 2021-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Genzyme Corporation | $935.28 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $889.47 | 2021-2025 | Uptravi, Opsumit |
| Grifols USA, LLC | $617.01 | 2021-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $615.51 | 2021-2025 | Dupixent |
| Electromed, INC. | $414.71 | 2021-2024 | Smartvest |
| Mylan Specialty L.P. | $404.34 | 2021-2024 | Yupelri |
| Amgen INC. | $390.89 | 2021-2025 | Tezspire, Otezla, Repatha |
| Inspire Medical Systems, INC. | $367.87 | 2024-2025 | Inspire |
| Mallinckrodt Hospital Products INC. | $360.38 | 2021-2025 | Acthar |
| Merck Sharp & Dohme LLC | $342.41 | 2024-2025 | Winrevair, Zerbaxa, Dificid |
| Pfizer INC. | $233.81 | 2023-2025 | |
| Verona Pharma, INC. | $220.78 | 2025 | Ohtuvayre |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $203.62 | 2022-2024 | Jardiance, Emgality, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $186.26 | 2021-2025 | Glassia |
| Inogen, INC. | $160.38 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Philips North America LLC | $149.61 | 2021-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| United Therapeutics Corporation | $148.33 | 2021-2023 | Tyvaso |
| Biotronik INC. | $129.90 | 2023 | Acticor 7 Vr-T Dx, Biomonitor, Edora 8 Dr-T |
| Bayer Healthcare Pharmaceuticals INC. | $122.13 | 2021-2023 | |
| Pulmonx Corporation | $103.45 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Kowa Pharmaceuticals America, INC. | $96.26 | 2021-2022 | |
| Viatris Specialty LLC | $95.34 | 2025 | Yupelri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.49 | 2022-2024 | Xifaxan |
| Teva Pharmaceuticals USA, INC. | $85.12 | 2021-2022 | |
| Axsome Therapeutics, INC. | $81.82 | 2023-2024 | Sunosi |
| Insmed, INC. | $76.78 | 2021-2025 | Brinsupri, Arikayce |
| Abbvie INC. | $74.85 | 2022-2024 | |
| Novo Nordisk INC | $65.30 | 2021-2023 | Wegovy, Rybelsus, Ozempic |
| Jazz Pharmaceuticals INC. | $62.70 | 2021-2022 | |
| Exact Sciences Corporation | $51.41 | 2023-2025 | Cologuard Collection Kit |
| Fisher & Paykel Healthcare INC | $43.38 | 2022 | |
| 3b Medical, INC. | $41.33 | 2024-2025 | Luna |
| Paratek Pharmaceuticals, INC. | $35.03 | 2021-2022 | |
| Vifor Pharma, INC. | $26.22 | 2025 | Zemaira |
| Almatica Pharma LLC | $23.52 | 2022 | |
| Alexion Pharmaceuticals, INC. | $21.65 | 2022 | |
| Idorsia Pharmaceuticals US INC | $18.74 | 2023 | Quviviq |
| Ani Pharmaceuticals, INC. | $17.43 | 2024 | Purified Cortrophin Gel |
| Advanced Respiratory, INC | $17.27 | 2021 | |
| Kaleo, INC. | $17.04 | 2021 | |
| Currax Pharmaceuticals LLC | $16.14 | 2022 | |
| Baxter Healthcare | $14.85 | 2023 | Hillrom - Life 2000 Ventilation System |
| Amarin Pharma, INC. | $13.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Kerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.